Buscar
Mostrando ítems 21-30 de 556
SARS-CoV-2 spike protein S1 activates Cx43 hemichannels and disturbs intracellular Ca2+ dynamics
(BioMed Central Ltd, 2024)
Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients
T cell immunity toward SARS-CoV-2 spike (S-), membrane (M-), and nucleocapsid (N-) proteins may define
COVID-19 severity. Therefore, we compare the SARS-CoV-2-reactive T cell responses in moderate, severe,
and critical ...
Production of a monoclonal antibody against SARS-CoV-2 and determination of viral neutralization capacity
(Fiocruz/Instituto de Tecnologia em Imunobiológicos, 2021)
The architecture of inactivated SARS-COV-2 with postfusion spikes revealed by cryo-em and cryo-et
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) resulted from the outbreak of SARSCoV-2 in December 2019. Currently, multiple efforts are being made to rapidly develop vaccines and treatments to fight ...
The current understanding and potential therapeutic options to combat COVID-19
The ongoing wreaking global outbreak of the novel human beta coronavirus (CoV) pathogen was presumed to be
from a seafood wholesale market in Wuhan, China, belongs to the Coronaviridae family in the Nidovirales order.
The ...
Essential functional molecules associated with SARS-CoV-2 infection: Poten‐ tial therapeutic targets for COVID-19
The whole world is still suffering substantially from the coronavirus disease 2019 (COVID19) outbreak. Several protein-based molecules that are associated with the Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), ...
Pannexin-1 channel opening is critical for COVID-19 pathogenesis
(CELL PRESS, 2021)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly rampaged worldwide, causing a pandemic of coronavirus disease (COVID-19), but the biology of SARS-CoV-2 remains under investigation. We demonstrate that ...